Grady Earns National Reaccreditation from the Commission on Cancer
September 12, 2023
Grady Health System’s Cancer Center for Excellence has earned reaccreditation from the Commission on Cancer (CoC), a quality program of the American College of Surgeons. To achieve CoC accreditation, Grady underwent a site visit to confirm the program’s compliance with accreditation standards that evaluate the cancer care services offered by the program.
As a CoC-accredited cancer center, Grady applies a multidisciplinary approach and treats cancer as a complex group of diseases that requires consultation among surgeons, medical and radiation oncologists, diagnostic radiologists, pathologists, and other cancer specialists.
“This accreditation demonstrates Grady’s commitment to providing top-notch, patient-centered cancer care,” said Pooja Mishra, Vice President of Oncology and Sickle Cell at Grady. “Not only do our patients receive the full range of services necessary to diagnose and treat their cancer, but they also have access to clinical trials, screening and prevention events, palliative care, genetic counseling, rehabilitation, oncology nutrition, and survivorship services.”
Grady maintains a cancer registry and contributes data to the National Cancer Database, a joint initiative of the CoC and the American Cancer Society. This clinical oncology database is sourced from hospital registry data collected from CoC-accredited facilities. These data are used to analyze and track patients’ diseases, treatments, and outcomes. Online reporting tools provide the program with comparative benchmarks for similar programs. In addition, the program has access to reporting tools for quality improvement, quality assurance, and surveillance.
Established in 1922 by the American College of Surgeons, the CoC is a consortium of professional organizations dedicated to improving patient outcomes and quality of life for cancer patients through standard-setting, prevention, research, education, and the monitoring of comprehensive, quality care. For more information, visit www.facs.org/cancer.
